Patients continued taking their medications for pulmonary arterial hypertension (PAH) when symptoms appeared to improve, according to a new survey. Professional guidelines say that when pulmonary ...

A possibly more precise risk model showed Adempas helped PAH patients at intermediate risk of death arrive at more favorable ...

Pulmonary arterial hypertension causes the small lung arteries to become narrow, stiff, or thickened. PAH is often idiopathic ...

While high blood pressure can contribute to renovascular disease, having renal (kidney) problems can also increase blood ...

PAH is a rare condition in children, but is often fatal if left untreated, and protocols for pediatric patients have not been well-studied, according to Lewis H. Romer, MD, of Johns Hopkins University ...

Exercise PH — measured by the mPAP/CO slope — may predict survival in patients with normal or mildly elevated pulmonary arterial pressure.

to treat pulmonary arterial hypertension (PAH) in the adult population. The therapy is used along with other PAH medications to improve exercise capacity in patients with moderate to severe ...

A month after halting dosing in two of the three treatment arms of a phase 2 trial of its pulmonary arterial hypertension ...

and pulmonary hypertension may be particularly relevant to the pathophysiology heart failure in patients with preserved ejection fraction, there is compelling rationale for extending the ...